Analysed AKESO INC (AKESF:OTCMKTS) News Sources
Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026
07-04-2026
yahoo.com
Ivonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026
31-03-2026
yahoo.com
Summit Therapeutics (SMMT) Is Up 6.9% After Phase III Ivonescimab Data And FDA Filing - What's Changed
28-03-2026
yahoo.com
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
27-03-2026
yahoo.com
Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab
25-03-2026
yahoo.com
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
16-03-2026
yahoo.com
What is the current price of AKESO INC (AKESF:OTCMKTS)?
The current price of AKESO INC (AKESF:OTCMKTS) is $17.57.
AKESO INC (AKESF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AKESO INC (AKESF:OTCMKTS) since the previous trading day is $0.52.
AKESO INC (AKESF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AKESO INC (AKESF:OTCMKTS) since the previous trading day is 3.0499%.
What is the most recent average sentiment score for AKESO INC (AKESF:OTCMKTS)?
The most recent average sentiment score for AKESO INC (AKESF:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for AKESO INC (AKESF:OTCMKTS)?
The most recent sentiment for AKESO INC (AKESF:OTCMKTS) is .
SEC-8K** Filing Available For AKESO INC (AKESF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.